UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
2176
DELISTED
Avidity Biosciences
RNAM
| $582K | ﹤0.01% |
91,165
+34,859
| +62% | +$300K |
|
|
ONC
2177
BeOne Medicines Ltd
ONC
$32.8B
| $582K | ﹤0.01% |
3,233
-405
| -11% | -$80.1K |
|
2178
Planet Labs
PL
$7.3B
| $581K | ﹤0.01% |
223,603
+24,023
| +12% | +$76.3K |
|
|
MAXN
2179
DELISTED
Maxeon Solar Technologies
MAXN
| $579K | ﹤0.01% |
500
+226
| +82% | +$429K |
|
2180
Health Catalyst
HCAT
$154M
| $577K | ﹤0.01% |
57,056
| – | – |
|
|
VMEO
2181
DELISTED
Vimeo
VMEO
| $575K | ﹤0.01% |
162,481
+38,011
| +31% | +$151K |
|
2182
AdaptHealth
AHCO
$1.47B
| $574K | ﹤0.01% |
63,063
+10,031
| +19% | +$120K |
|
|
NGMS
2183
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $572K | ﹤0.01% |
21,200
+2,200
| +12% | +$59.4K |
|
2184
Lightwave Logic
LWLG
$995M
| $572K | ﹤0.01% |
127,903
+37,328
| +41% | +$238K |
|
2185
Argan
AGX
$8B
| $572K | ﹤0.01% |
12,556
| – | – |
|
|
AAMI
2186
Acadian Asset Management
AAMI
$3.08B
| $571K | ﹤0.01% |
29,435
-18,827
| -39% | -$389K |
|
|
ATRI
2187
DELISTED
Atrion Corp
ATRI
| $570K | ﹤0.01% |
1,379
+145
| +12% | +$72.8K |
|
|
CDMO
2188
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $570K | ﹤0.01% |
60,331
| – | – |
|
2189
First Community Bankshares
FCBC
$900M
| $567K | ﹤0.01% |
19,260
+6,919
| +56% | +$218K |
|
2190
Vanguard Industrials ETF
VIS
$8.1B
| $565K | ﹤0.01% |
+2,898
| New | +$595K |
|
2191
MBIA
MBI
$261M
| $564K | ﹤0.01% |
78,292
| – | – |
|
|
FINV
2192
FinVolution Group
FINV
$1.15B
| $564K | ﹤0.01% |
113,344
| – | – |
|
|
CFB
2193
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $564K | ﹤0.01% |
55,896
+8,803
| +19% | +$95.9K |
|
2194
CareDx
CDNA
$2.26B
| $563K | ﹤0.01% |
80,489
+7,172
| +10% | +$66.3K |
|
|
SP
2195
DELISTED
SP Plus Corporation
SP
| $560K | ﹤0.01% |
15,525
+5,601
| +56% | +$217K |
|
2196
Evolus
EOLS
$385M
| $559K | ﹤0.01% |
61,214
| – | – |
|
2197
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.71B
| – | – |
0
| – | – |
|
2198
Alkami Technology
ALKT
$1.94B
| $557K | ﹤0.01% |
+30,548
| New | +$513K |
|
|
LAND
2199
Gladstone Land Corp
LAND
$350M
| $551K | ﹤0.01% |
38,707
+5,670
| +17% | +$90.3K |
|
|
WSR
2200
DELISTED
Whitestone REIT
WSR
| $547K | ﹤0.01% |
56,791
+17,823
| +46% | +$178K |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.